Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Hertig

Showing results (91-100 of 188) with videos related to

Pageof 19
Sort By:
Clinical Chemistry and Laboratory Medicine|April 3, 2020
Decision-making based on sFlt-1/PlGF ratios: are immunoassay results interchangeable for diagnosis or prognosis of preeclampsia?Guillaume Lefèvre, Alexandre Hertig, Jean Guibourdenche, et al.
Endocrine Reviews|March 22, 2017
From Pregnancy to Preeclampsia: A Key Role for EstrogensNadia Berkane, Philippe Liere, Jean-Paul Oudinet, et al.
Transplantation|September 13, 2011
Epithelial phenotypic changes detect cyclosporine in vivo nephrotoxicity at a reversible stagePierre Galichon, Nathalie Vittoz, Yi-Chun Xu-Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2021
Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature reviewLee S Nguyen, Sofia Ortuno, Bénédicte Lebrun-Vignes, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2014
Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in miceDominique Cathelin, Sandrine Placier, Michael Ploug, et al.
La Revue Du Praticien|March 15, 2022
[Nutritionnal complications and patients follow-up after bariatric surgery]Alexandre Nuzzo, Sébastien Czernichow, Alexandre Hertig, et al.
Transplantation|May 1, 2002
Chronic graft dysfunction in renal transplant patients: potential role of plasminogen activator inhibitor type 1Anis Lahlou, Marie-Noëlle Peraldi, Eric Thervet, et al.
The Lancet. Gastroenterology & Hepatology|February 14, 2021
Prevention and treatment of nutritional complications after bariatric surgeryAlexandre Nuzzo, Sebastien Czernichow, Alexandre Hertig, et al.
Journal of Clinical Medicine|August 26, 2022
Pregnancies and Gynecological Follow-Up after Solid Organ Transplantation: Experience of a DecadeAlice Bedin, Marie Carbonnel, Renaud Snanoudj, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 5, 2003
Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor betaAlexandre Hertig, Jeannig Berrou, Yves Allory, et al.
Pageof 19

Showing results (91-100 of 188) with videos related to

Sort By:
Pageof 19
Clinical Chemistry and Laboratory Medicine|April 3, 2020
Decision-making based on sFlt-1/PlGF ratios: are immunoassay results interchangeable for diagnosis or prognosis of preeclampsia?Guillaume Lefèvre, Alexandre Hertig, Jean Guibourdenche, et al.
Endocrine Reviews|March 22, 2017
From Pregnancy to Preeclampsia: A Key Role for EstrogensNadia Berkane, Philippe Liere, Jean-Paul Oudinet, et al.
Transplantation|September 13, 2011
Epithelial phenotypic changes detect cyclosporine in vivo nephrotoxicity at a reversible stagePierre Galichon, Nathalie Vittoz, Yi-Chun Xu-Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2021
Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature reviewLee S Nguyen, Sofia Ortuno, Bénédicte Lebrun-Vignes, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2014
Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in miceDominique Cathelin, Sandrine Placier, Michael Ploug, et al.
La Revue Du Praticien|March 15, 2022
[Nutritionnal complications and patients follow-up after bariatric surgery]Alexandre Nuzzo, Sébastien Czernichow, Alexandre Hertig, et al.
Transplantation|May 1, 2002
Chronic graft dysfunction in renal transplant patients: potential role of plasminogen activator inhibitor type 1Anis Lahlou, Marie-Noëlle Peraldi, Eric Thervet, et al.
The Lancet. Gastroenterology & Hepatology|February 14, 2021
Prevention and treatment of nutritional complications after bariatric surgeryAlexandre Nuzzo, Sebastien Czernichow, Alexandre Hertig, et al.
Journal of Clinical Medicine|August 26, 2022
Pregnancies and Gynecological Follow-Up after Solid Organ Transplantation: Experience of a DecadeAlice Bedin, Marie Carbonnel, Renaud Snanoudj, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 5, 2003
Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor betaAlexandre Hertig, Jeannig Berrou, Yves Allory, et al.
Pageof 19